Statistics

Total Visits

Views
Verteporfin photodynamic therapy combined with intravitreal ranibizumab for polypoidal choroidal vasculopathy controversy concerning long-term followup.16

Select a period of time:

Number of views in the range

Views
Verteporfin photodynamic therapy combined with intravitreal ranibizumab for polypoidal choroidal vasculopathy controversy concerning long-term followup.9

Views

Views
May 20245
June 20240
July 20241
August 20242
September 20241
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
United Kingdom1
 

Top cities views

Views
Chicago3
Fort Worth1